ArticleIndian journal of pharmacology2026
Cytotoxic screening for three extracts of two plants using MTT assay and flow cytometric techniques.
Article in Indian journal of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study was set out to screen the cytotoxic activity of three extracts of two plants against three cancer cell lines.
methodsCytotoxic activity of three extracts of these two plants (Haplophyllum tuberculatum (H) and Sonchus oleraceus L.(S)) was tested against three cell lines: HeLa uterus (H2), A431 skin (A2), and MCF breast (M2) using the MTT assay and the flow cytometric technique in vitro.
resultsThe results revealed that similar yield percentages were obtained. Extract fractions from the first plant HF3 exerted high effects (>75%) on the three cell lines. The aqueous extract of HF3 exhibited significant (P < 0.001) cell growth inhibition activities estimated as (inhibitory concentration 50 in m/mL) of (0.73 ± 0.08, 0.7566 ± 0.12, and 0.65 ± 0.04) on the HeLa, A431, and MCF7 cells, respectively, compared to standard doxorubicin.
conclusionsThe study concluded that similar yield percentages were obtained. Plant H exhibited higher activity, especially in its aqueous extract. Isolation, identification of the active (s) compounds, and determination of the mechanism of action were highly required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.